Simple and rapid discrimination of embB codon 306 mutations in Mycobacterium tuberculosis clinical isolates by a real-time PCR assay using an LNA-TaqMan probe

Journal of Microbiological Methods

Volumn 92, Issue 3, 2013, Pages 301-306

  Yoon, Jee Hyun ^a   Nam, Ji Sun ^a   Kim, Kyung Jin ^a   Ro, Young Tae ^a  

^a Konkuk University School of Medicine   (South Korea)

Author keywords

EmbB306 mutations; Genotype analysis; LNA TaqMan probe; Mycobacterium tuberculosis; Real time PCR

Indexed keywords

GENOMIC DNA; LOCKED NUCLEIC ACID;

ARTICLE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CODON; CONTROLLED STUDY; DNA PROBE; DNA SEQUENCE; EMBB GENE; FLUORESCENCE ANALYSIS; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENETIC SCREENING; HYDROLYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; ETHAMBUTOL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; MYCOBACTERIUM TUBERCULOSIS; OLIGONUCLEOTIDE PROBES; PENTOSYLTRANSFERASES; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TUBERCULOSIS;

EID: 84873738459     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2012.12.014     Document Type: Article

References (38)

1. Ahmad S., Mokaddas E., Jaber A.A. Rapid detection of ethambutol-resistant Mycobacterium tuberculosis strains by PCR-RFLP targeting embB codons 306 and 497 and iniA codon 501 mutations. Mol. Cell. Probes 2004, 18:299-306.
2. Ahmad S., Jaber A.A., Mokaddas E. Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait. Tuberculosis (Edinb.) 2007, 87:123-129.
3. Alcaide F., Pfyffer G.E., Telenti A. Role of embB in natural and acquired resistance to ethambutol in mycobacteria. Antimicrob. Agents Chemother. 1997, 41:2270-2273.
4. Brewer T.F., Heymann S.J. Long time due: reducing tuberculosis mortality in the 21st century. Arch. Med. Res. 2005, 36:617-621.
5. Chan R.C., Hui M., Chan E.W., Au T.K., Chin M.L., Yip C.K., et al. Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J. Antimicrob. Chemother. 2007, 59:866-873.
6. Espasa M., González-Martín J., Alcaide F., Aragón L.M., Lonca J., Manterola J.M., et al. Direct detection in clinical samples of multiple gene mutations causing resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using fluorogenic probes. J. Antimicrob. Chemother. 2005, 55:860-865.
7. Guo H., Seet Q., Denkin S., Parsons L., Zhang Y. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA. J. Med. Microbiol. 2006, 55:1527-1531.
8. Hazbón M.H., Bobadilla del Valle M., Guerrero M.I., Varma-Basil M., Filliol I., Cavatore M., et al. Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob. Agents Chemother. 2005, 49:3794-3802.
9. Isola D., Pardini M., Varaine F., Niemann S., Rüsch-Gerdes S., Fattorini L., et al. A Pyrosequencing assay for rapid recognition of SNPs in Mycobacterium tuberculosis embB306 region. J. Microbiol. Methods 2005, 62:113-120.
10. Johnson M.P., Haupt L.M., Griffiths L.R. Locked nucleic acid (LNA) single nucleotide polymorphism (SNP) genotype analysis and validation using real-time PCR. Nucleic Acids Res. 2004, 32:e55.
11. Kaur H., Arora A., Wengel J., Maiti S. Thermodynamic, counterion, and hydration effects for the incorporation of locked nucleic acid nucleotides into DNA duplexes. Biochemistry 2006, 45:7347-7355.
12. Lee H.Y., Myoung H.J., Bang H.E., Bai G.H., Kim S.J., Kim J.D., et al. Mutations in the embB locus among Korean clinical isolates of Mycobacterium tuberculosis resistant to ethambutol. Yonsei Med. J. 2002, 43:59-64.
13. Lee A.S., Othman S.N.K., Ho Y.M., Wong S.Y. Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2004, 48:4447-4449.
14. Luo T., Jiang L., Sun W., Fu G., Mei J., Gao Q. Multiplex real-time PCR melting curve assay to detect drug-resistant mutations of Mycobacterium tuberculosis. J. Clin. Microbiol. 2011, 49:3132-3138.
15. Lyon E., Wittwer C.T. LightCycler technology in molecular diagnostics. J. Mol. Diagn. 2009, 11:93-101.
16. Mahadevan M.S., Benson P.V. Factor V null mutation affecting the Roche LightCycler factor V Leiden assay. Clin. Chem. 2005, 51:1533-1535.
17. Mokrousov I., Narvskaya O., Limeschenko E., Otten T., Vyshnevskiy B. Detection of ethambutol-resistant Mycobacterium tuberculosis strains by multiplex allele-specific PCR assay targeting embB306 mutations. J. Clin. Microbiol. 2002, 40:1617-1620.
18. Mokrousov I., Otten T., Vyshnevskiy B., Narvskaya O. Detection of embB306 mutations in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis from Northwestern Russia: Implications for genotypic resistance testing. J. Clin. Microbiol. 2002, 40:3810-3813.
19. Morris S., Bai G.H., Suffys P., Portillo-Gomez L., Fairchok M., Rouse D. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J. Infect. Dis. 1995, 171:954-960.
20. Musser J.M. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev. 1995, 8:496-514.
21. Palomino J.C. Molecular detection, identification and drug resistance detection in Mycobacterium tuberculosis. FEMS Immunol. Med. Microbiol. 2009, 56:103-111.
22. Plinke C., Rüsch-Gerdes S., Niemann S. Significance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 2006, 50:1900-1902.
23. Plinke C., Cox H.S., Kalon S., Doshetov D., Rüsch-Gerdes S., Niemann S. Tuberculosis ethambutol resistance: concordance between phenotypic and genotypic test results. Tuberculosis (Edinb.) 2009, 89:448-452.
24. Ramaswamy S., Musser J.M. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 1998, 79:3-29.
25. Ramaswamy S.V., Amin A.G., Göksel S., Stager C.E., Dou S.J., El Sahly H., et al. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2000, 44:326-336.
26. Reed G.H., Kent J.O., Wittwer C.T. High-resolution DNA melting analysis for simple and efficient molecular diagnostics. Pharmacogenomics 2007, 8:597-608.
27. Rinder H., Mieskes K.T., Tortoli E., Richter E., Casal M., Vaquero M., et al. Detection of embB codon 306 mutations in ethambutol resistant Mycobacterium tuberculosis directly from sputum samples: a low-cost, rapid approach. Mol. Cell. Probes 2001, 15:37-42.
28. Ronaghi M. Pyrosequencing sheds light on DNA sequencing. Genome Res. 2001, 11:3-11.
29. Ronaghi M., Karamohamed S., Pettersson B., Uhlén M., Nyrén P. Real-time DNA sequencing using detection of pyrophosphate release. Anal. Biochem. 1996, 242:84-89.
30. SantaLucia J. A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:1460-1465.
31. Shen X., Shen G.M., Wu J., Gui X.H., Li X., Mei J., et al. Association between embB codon 306 mutations and drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2007, 51:2618-2620.
32. Somoskovi A., Parsons L.M., Salfinger M. The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Respir. Res. 2001, 2:164-168.
33. Sreevatsan S., Stockbauer K.E., Pan X., Kreiswirth B.N., Moghazeh S.L., Jacobs W.R., et al. Ethambutol resistance in Mycobacterium tuberculosis: Critical role of embB mutations. Antimicrob. Agents Chemother. 1997, 41:1677-1681.
34. Telenti A., Imboden P., Marchesi F., Lowrie D., Cole S., Colston M.J., et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993, 341:647-650.
35. Ugozzoli L.A., Latorra D., Pucket R., Arar K., Hamby K. Real-time genotyping with oligonucleotide probes containing locked nucleic acids. Anal. Biochem. 2004, 324:143-152.
36. Victor T.C., Jordaan A.M., van Rie A., van der Spuy G.D., Richardson M., van Helden P.D., et al. Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy. Tuber. Lung Dis. 1999, 79:343-348.
37. Whelan J.A., Russell N.B., Whelan M.A. A method for the absolute quantification of cDNA using real-time PCR. J. Immunol. Methods 2003, 278:261-269.
38. Yoon J.H., Nam J.S., Kim K.J., Choi Y., Lee H., Cho S.N., et al. Molecular characterization of drug-resistant and -susceptible Mycobacterium tuberculosis isolated from patients with tuberculosis in Korea. Diagn. Microbiol. Infect. Dis. 2012, 72:52-61.